2025
SJR Q3
JCR Q4 · 0,6
OA
8 eşleşen makale
SCIE
Dergi ayrıntısı
Stem Cell Research
- Yayıncı
- Elsevier B.V.
- Ülke
- Netherlands · Western Europe
- Tür
- journal
- ISSN
-
1873506118767753
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,333
- Quartile Q3
- H-Index 86
- Atıf/yayın 0,63
- Doküman (3y) 973
- Atıf (3y) 593
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 0,6
- 5Y JIF 0,8
- JCI 0,13
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Cell Biology Q4
- Developmental Biology Q4
- Medicine (miscellaneous) Q3
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Medicine
WoS kategorileri
- Cell & Tissue Engineering | Biotechnology & Applied Microbiology | Cell Biology
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,333 | 0,6 | 0,8 | 0,13 | Q4 | 86 |
| 2024 | Q3 | Q4 | 0,495 | 0,7 | 1 | 0,18 | Q4 | 82 |
| 2023 | Q3 | Q4 | 0,467 | 0,8 | 1,1 | 0,22 | Q4 | 82 |
| 2022 | Q2 | Q4 | 0,521 | 1,2 | 1,5 | 0,28 | Q4 | 82 |
| 2021 | Q3 | Q4 | 0,482 | 1,6 | 2,1 | 0,33 | Q4 | 82 |
| 2020 | Q2 | Q4 | 0,654 | 2 | 2,5 | 0,4 | Q4 | 82 |
| 2019 | Q2 | Q1 | 0,688 | 4,5 | 4,4 | 0,49 | Q3 | 82 |
| 2018 | — | Q1 | — | 3,9 | 4,2 | 0,56 | Q3 | — |
| 2017 | Q1 | Q1 | 1,214 | 3,9 | 4,1 | 0,84 | Q2 | 82 |
| 2016 | Q1 | Q1 | 1,976 | 4 | 4,1 | — | — | 82 |
| 2015 | Q1 | Q1 | 2,051 | 3,9 | 4 | — | — | 82 |
| 2014 | Q1 | Q1 | 1,828 | 3,7 | 4,2 | — | — | 82 |
| 2013 | Q1 | Q1 | 1,88 | 3,9 | 4,4 | — | — | 82 |
| 2012 | Q1 | Q1 | 1,823 | 4,5 | 4,8 | — | — | 82 |
| 2011 | Q1 | Q1 | 2,353 | 5,1 | 5,2 | — | — | 82 |
| 2010 | Q1 | Q1 | 1,724 | 3,4 | 4,1 | — | — | 82 |
| 2009 | — | Q1 | — | 3,4 | 3,5 | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q4 | 172/180 |
| 2025 | CELL BIOLOGY | SCIE | Q4 | Q4 | 203/207 |
| 2025 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 32/32 |
| 2024 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q4 | 168/177 |
| 2024 | CELL BIOLOGY | SCIE | Q4 | Q4 | 201/204 |
| 2024 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 32/32 |
| 2023 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q4 | 166/174 |
| 2023 | CELL BIOLOGY | SCIE | Q4 | Q4 | 200/205 |
| 2023 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 31/31 |
| 2022 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q4 | 148/158 |
| 2022 | CELL BIOLOGY | SCIE | Q4 | Q4 | 186/191 |
| 2022 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 28/29 |
| 2021 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q4 | 146/159 |
| 2021 | CELL BIOLOGY | SCIE | Q4 | Q4 | 186/195 |
| 2021 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 28/29 |
| 2020 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q4 | Q4 | 131/159 |
| 2020 | CELL BIOLOGY | SCIE | Q4 | Q4 | 175/195 |
| 2020 | CELL & TISSUE ENGINEERING | SCIE | Q4 | Q4 | 27/29 |
| 2019 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q3 | 28/156 |
| 2019 | CELL BIOLOGY | SCIE | Q2 | Q3 | 68/195 |
| 2019 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q4 | 11/29 |
| 2018 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q3 | 34/162 |
| 2018 | CELL BIOLOGY | SCIE | Q2 | Q3 | 80/193 |
| 2018 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q3 | 9/26 |
| 2017 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | Q2 | 34/161 |
| 2017 | CELL BIOLOGY | SCIE | Q2 | Q2 | 74/190 |
| 2017 | CELL & TISSUE ENGINEERING | SCIE | Q2 | Q2 | 10/24 |
| 2016 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 30/160 |
| 2016 | CELL BIOLOGY | SCIE | Q2 | — | 71/190 |
| 2016 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 8/21 |
| 2015 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 30/161 |
| 2015 | CELL BIOLOGY | SCIE | Q2 | — | 70/187 |
| 2015 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 7/21 |
| 2014 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 31/163 |
| 2014 | CELL BIOLOGY | SCIE | Q2 | — | 75/184 |
| 2014 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 9/21 |
| 2013 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 31/165 |
| 2013 | CELL BIOLOGY | SCIE | Q2 | — | 75/185 |
| 2013 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 7/18 |
| 2012 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 20/160 |
| 2012 | CELL BIOLOGY | SCIE | Q2 | — | 58/185 |
| 2012 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 6/17 |
| 2011 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 18/158 |
| 2011 | CELL BIOLOGY | SCIE | Q2 | — | 48/181 |
| 2011 | CELL & TISSUE ENGINEERING | SCIE | Q1 | — | 3/12 |
| 2010 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 37/160 |
| 2010 | CELL BIOLOGY | SCIE | Q2 | — | 88/178 |
| 2010 | CELL & TISSUE ENGINEERING | SCIE | Q3 | — | 7/13 |
| 2009 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | SCIE | Q1 | — | 36/152 |
| 2009 | CELL BIOLOGY | SCIE | Q2 | — | 77/162 |
| 2009 | CELL & TISSUE ENGINEERING | SCIE | Q2 | — | 6/12 |